Chen Lina, Li Senhao, Ai Lanmu, Zhou Jun, Huang Junlin, Xu Feng, Zeng Xiangyuan, Han Jia, Yin Fangxue, Zhu Yixin, Xie Yifang
Shaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
College of Medicine, Shaoxing University, Shaoxing, Zhejiang, China.
Infect Microbes Dis. 2020 Nov 4;2(4):136-143. doi: 10.1097/IM9.0000000000000042. eCollection 2020 Dec.
Heart failure (HF) is a global public health problem, with morbidity and mortality increasing year by year. The gut microbiome actively affects the physiological and pathological activities of the human body in a variety of ways. More and more studies have suggested a strong correlation between HF and gut microbiome metabolites. Our review summarizes the specific alteration of these metabolites and their connection to the progression of HF, aiming at considering new approaches toward regulating the gut microbiome and using its metabolic pathways to treat HF, potentially decreasing the morbidity and mortality of HF as well as improving prognosis.
心力衰竭(HF)是一个全球性的公共卫生问题,其发病率和死亡率逐年上升。肠道微生物群以多种方式积极影响人体的生理和病理活动。越来越多的研究表明HF与肠道微生物群代谢产物之间存在密切关联。我们的综述总结了这些代谢产物的具体变化及其与HF进展的联系,旨在探索调节肠道微生物群的新方法,并利用其代谢途径治疗HF,有望降低HF的发病率和死亡率并改善预后。